z-logo
open-access-imgOpen Access
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival
Author(s) -
Ghaith AbuZeinah,
Spencer Krichevsky,
Tatiana Cruz,
Gabriela Hoberman,
Diana Jaber,
Niamh Savage,
Claudia Sosner,
Ellen K. Ritchie,
Joseph M. Scandura,
Richard T. Silver
Publication year - 2021
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01183-8
Subject(s) - myelofibrosis , medicine , polycythemia vera , gastroenterology , phlebotomy , alpha interferon , ruxolitinib , retrospective cohort study , lower risk , confidence interval , surgery , interferon , immunology , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom